ليست عنوان مقالات لاتين Neural-network-based load modeling and its use in voltage stability analysis Neuromuscular function and bone density as independent predictors of fracture in older women: A 10-year longitudinal study

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Neural-network-based load modeling and its use in voltage stability analysis

2

Neural-network-based maximum power point tracking methods for photovoltaic systems operating under fast changing environments

3

Neural-network-based maximum-power-point tracking of coupled-inductor interleaved-boost-converter-supplied PV system using fuzzy controller

4

Neural-network-based model reference adaptive systems for high-performance motor drives and motion controls

5

Neural-network-based models for generating artificial earthquakes and response spectra

6

Neural-network-based motor rolling bearing fault diagnosis

7

Neural-Network-Based Numerical Control for Milling Machine

8

Neural-network-based optimal fuzzy controller design for nonlinear systems

9

Neural-network-based payload determination of a moving loader

10

Neural-network-based prediction of mooring forces in floating production storage and offloading systems

11

Neural-network-based regression model of ground surface settlement induced by deep excavation

12

Neural-network-based reliability analysis: a comparative study Original Research Article

13

Neural-network-based self-organized fuzzy logic control for arc welding

14

Neural-Network-Based Sensorless Maximum Wind Energy Capture With Compensated Power Coefficient

15

Neural-network-based water inflow forecasting

16

Neural-network-based waveform Processing and Delayless filtering in power electronics and AC drives

17

Neural-network-identification-based adaptive control of wing rock motions

18

Neural-networks for predicting the operation of an under-frequency load shedding system

19

NeuralNEURAL NETWORK CONTROL OF TWO 6 DOF ELECTRICALLY DRIVEN COOPERATING ROBOT MANIPULATORS CARRYING A RIGID OBJECT

20

Neural-optimal control algorithm for real-time regulation of in-line storage in combined sewer systems

21

Neural-Symbolic Learning and Reasoning Workshop at IJCAI-05, Edinburgh, Scotland

22

Neural-wavelet Methodology for Load Forecasting

23

Neural-Wiener-based Model Predictive Control (NWMPC) for Methyl Tert-butyl Ether Catalytic Distillation

24

Neuraminidase inhibitor and amantadine

25

Neuraminidase inhibitors for treatment of equine influenza – when all else fails?

26

Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study

27

Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities Original Research Article

28

Neuraminidase pharmacophore model derived from diverse classes of inhibitors

29

Neuraminidase produces dose-dependent decrease of slime production and adherence of slime-forming, coagulase-negative staphylococci

30

Neurasthenia: cross-cultural and conceptual issues in relation to chronic fatigue syndrome

31

Neuraxial block versus general anaesthesia for cesarean section: post-operative pain scores and analgesic requirements

32

Neuraxial Dexmedetomidine: Wonder Drug or Simply Harmful

33

Neurectomy for Treatment of Intercostal Neuralgia

34

Neuregulin 1 and Schizophrenia: Genetics, Gene Expression, and Neurobiology

35

Neuregulin 1-alpha expression in locally advanced breast cancer

36

Neuregulin 3 Genetic Variations and Susceptibility to Schizophrenia in a Chinese Population

37

Neuregulin 4 in Polycystic Ovarian Syndrome (PCOS) Phenotypes: A Key Role or Standby

38

Neuregulin activates erbB2-dependent src/FAK signaling and cytoskeletal remodeling in isolated adult rat cardiac myocytes

39

Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation–contraction coupling and reduces oxidative stress in adult rat cardiomyocytes

40

Neuregulin-1 Gene and Schizophrenia, and its Negative Symptoms in an Iranian Population

41

Neuregulin-1 Induces Expression of Egr-1 and Activates Acetylcholine Receptor Transcription Through an Egr-1-binding Site

42

Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt

43

Neuregulin-1 reduces ischemia-induced brain damage in rats

44

Neuregulin-1/ErbB signaling is impaired in the rat model of diabetic cardiomyopathy

45

Neuregulin1/ErbB4 Signaling Induces Cardiomyocyte Proliferation and Repair of Heart Injury

46

Neuregulin-1/erbB-Activation Improves Cardiac Function and Survival in Models of Ischemic, Dilated, and Viral Cardiomyopathy Original Research Article

47

Neuregulin-1-Mediated Autocrine Signaling Underlies Sensitivity to HER2 Kinase Inhibitors in a Subset of Human Cancers

48

Neuregulins Response to Exercise: a Mini Review

49

NEURENTERIC CYST OF THE CRANIOVERTEBRAL JUNCTION

50

neurex: a tutorial expert system for the diagnosis of neurogenic diseases of the lower limbs

51

Neurilemmoma of the Parotid Gland

52

Neurite bridging across micropatterned grooves

53

Neurite extension of primary neurons on electrospun piezoelectric scaffolds

54

Neurite Extension: Starting at the Finish Line

55

Neurite guidance on protein micropatterns generated by a piezoelectric microdispenser

56

Neurite Outgrowth on Chromaffin Cells Applying Extremely Low Frequency Magnetic Fields by Permanent Magnets

57

Neurite outgrowth on well-characterized surfaces: preparation and characterization of chemically and spatially controlled fibronectin and RGD substrates with good bioactivity

58

Neurite outgrowth, survival and branching pattern of the postnatal myenteric plexus in vitro is influenced by ethanol

59

Neuritic plaques detected non-invasively

60

Neuritogenic cerebrosides from an edible chinese mushroom. Part 2: structures of two additional termitomycesphins and activity enhancement of an inactive cerebroside by hydroxylation Original Research Article

61

NEuro COgnitive REhabilitation for Disease of Addiction (NECOREDA) Program: From Development to Trial

62

Neuro Cognitive Tracking and Corrective Action: A Way Forward in Academic Performance

63

Neuro fuzzy based predict the insulation quality of high voltage rotating machine

64

Neuro fuzzy model for predicting the dynamic characteristics of beams

65

NEURO IMAGING OF CNS LESIONS IN AIDS

66

Neuro tissue engineering of glial nerve guides and the impact of different cell types

67

Neuroacanthocytosis in Two Brothers: An Ultra-rare Cause of Movement Disorder

68

Neuro-ACT Cognitive Architecture Applications in Modeling Driver’s Steering Behavior in Turns

69

Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers

70

Neuroactive steroids are not affected by panic induction with 50 μg cholecystokinin-tetrapeptide (CCK-4) in healthy volunteers

71

Neuroactive Steroids in First-Episode Psychosis:A Role for Progesterone ?

72

Neuro-adaptive cooperative tracking control of unknown higher-order affine nonlinear systems

73

Neuro-adaptive hybrid controller for robot-manipulator tracking control

74

NEURO-ADAPTIVE VIBRATION CONTROL OF COMPOSITE BEAMS SUBJECT TO SUDDEN DELAMINATION

75

Neuroadrenergic activation and response to dobutamine in congestive heart failure secondary to idiopathic dilated cardiomyopathy

76

Neuroanatomic and Functional Correlates of Depressed Mood The Cardiovascular Health Study

77

Neuroanatomic contributions to slowed orienting of attention in children with autism

78

Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points

79

Neuroanatomic Map for Nerve Block Design in Breast Surgery

80

Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison

81

Neuroanatomical aging: Universal but not uniform

82

Neuroanatomical correlates of awareness of illness in patients with amnestic mild cognitive impairment who will or will not convert to Alzheimerʹs disease

83

Neuroanatomical correlates of familial language impairment: A preliminary report

84

Neuro-anatomical correlates of impaired retrieval of verbs and nouns: Interaction of grammatical class, imageability and actionality

85

Neuro-anatomical differences among epileptic and non-epileptic déjà-vu

86

Neuroanatomical discrimination between manipulating and maintaining processes involved in verbal working memory; a functional MRI study

87

Neuroanatomy and neurophysiology of the locust hypocerebral ganglion

88

Neuroanatomy in elbow arthroscopy

89

Neuroanatomy in Understanding Primate Brain Function: Status and Challenges

90

Neuroanatomy is Needed to Define the “Organs” of the Brain

91

Neuroanatomy of Alzheimerʹs disease: Hierarchical vulnerability and neural system compromise

92

Neuroanatomy of auditory verbal hallucinations in schizophrenia: A quantitative meta-analysis of voxel-based morphometry studies

93

Neuroanatomy of Cognition, Neuroanatomy and Cognition

94

Neuroanatomy of comorbid schizophrenia and learning disability: a controlled study

95

Neuroanatomy of impaired self-awareness in Alzheimerʹs disease and mild cognitive impairment

96

Neuroanatomy of the human affective system

97

Neuro-ANFIS Architecture for ECG Rhythm-Type Recognition Using Different QRS Geometrical-Based Features

98

Neuro-based formulation to predict fouling threshold in crude preheaters

99

Neurobehavior effects in four strains of mice offspring exposed prenatally to alprazolam

100

Neurobehavior in preterm neonates exposed to cocaine, alcohol, and tobacco

101

Neurobehavioral Alterations in Developing Transgenic Mice Expressing TNF-α in the Brain

102

Neurobehavioral and gestational effects of prenatal AZT exposure in Sprague-Dawley rats

103

Neurobehavioral and Neurophysiological Outcome of Chronic Low-Level Tetrachloroethene Exposure Measured in Neighborhoods of Dry Cleaning Shops

104

Neurobehavioral and Respiratory Findings in Jet Engine Repair Workers: A Comparison of Exposed and Unexposed Volunteers

105

Neurobehavioral and Social Sequelae of “Maajoune Illicit Drug” Use by Young Individuals

106

Neurobehavioral approach for evaluation of office workersʹ productivity: The effects of room temperature

107

Neurobehavioral assessment in forensic practice

108

Neurobehavioral Changes Among Workers in Some Chemical Industries in Egypt

109

Neurobehavioral Deficits in Persian Gulf Veterans: Additional Evidence from a Population-Based Study

110

Neurobehavioral Effects in Occupational Chemical Exposure Original Research Article

111

Neurobehavioral Effects of Chronic Occupational Exposure to Organic Solvents Among Japanese Industrial Painters

112

Neurobehavioral effects of exposure to trichloroethylene through a municipal water supply

113

Neurobehavioral Effects of Intrauterine Mercury Exposure: Potential Sources of Bias

114

Neurobehavioral Effects of Low-Level Methanol Vapor Exposure in Healthy Human Volunteers

115

Neurobehavioral Effects of Occupational Exposure to Low-Level Organic Solvents among Taiwanese Workers in Paint Factories, ,

116

Neurobehavioral Effects of Occupational Exposure to Organic Solvents Among Pharmaceutical Laboratory Workers in Iran

117

Neurobehavioral effects of power-frequency electromagnetic fields : N. Paneth, Environmental Health Perspectives Supplements, 101 (Suppl. 4)

118

Neurobehavioral Effects of Prolonged Exposure to Solid Air Freshener in Mice

119

Neurobehavioral Effects of Solvents: The Role of Alcohol

120

Neurobehavioral evaluation for a community with chronic exposure to hydrogen sulfide gas

121

Neurobehavioral frontal dysfunction in Alzheimerʹs disease with and without psychosis

122

Neurobehavioral Performance of Estate Residents with Privately-Treated Water Supply

123

Neuro-behavioral Profile and Toxicity of the Essential Oil of Dorema ‎ammoniacum Gum as an Anti-seizure, Anti-Nociceptive, an‎d Hypnotic Agent with Memory-‎enhancing Properties in D-Galactose Induced Aging Mice

124

Neurobehavioral sequelae of immunotherapy anaphylaxis

125

Neurobehavioral Symptoms and Family Functioning in Traumatically Brain-Injured Adults

126

Neurobehavioral tests are monitoring tools used to improve cardiac surgery outcome

127

Neurobehavioral Tests as a Medical Surveillance Procedure: Applying Evaluative Criteria

128

Neurobehavioral Toxicology in the 21st Century: A Future or a Failure? : The 1991 Hänninen Lecture

129

Neurobehavioural sequelae of cardiopulmonary b ypass

130

Neurobiochemical and clinical aspects of craving in alcohol addiction: A review

131

Neurobiochemical changes from Taxol/Neupogen chemotherapy for metastatic breast carcinoma corresponds with suicidal depression

132

Neurobiologic characteristics of umbilical artery lactate levels

133

Neurobiologic mechanisms of fetal heart rate response to vibroacoustic stimulation

134

Neurobiologic responses to speech in noise in children with learning problems: deficits and strategies for improvement

135

Neurobiological abnormalities in the relatives of schizophrenics

136

Neurobiological adaptations to violence across development

137

Neurobiological correlates of high (HAB) versus low anxiety-related behavior (LAB): differential Fos expression in HAB and LAB rats

138

Neurobiological Correlates of Social Conformity and Independence During Mental Rotation

139

Neurobiological mechanisms contributing to alcohol–stress–anxiety interactions

140

Neurobiological mechanisms of nicotine craving

141

Neurobiological mechanisms of relapse

142

Neurobiological parameters and anorexia nervosa: Findings from animal studies

143

Neurobiological perspectives on social phobia: from affiliation to zoology

144

Neurobiological studies of reading and reading disability

145

Neurobiological substrate of dimensions of schizophrenic illness

146

Neurobiological substrates of behavioral decline: Models and data analytic strategies for individual differences in aging

147

Neurobiologie des troubles dissociatifs

148

Neurobiology and neurochemistry of Rett syndrome

149

Neurobiology and neuropathology underlie the neuropsychological deficits associated with traumatic brain injury

150

Neurobiology in the Treatment of Eating Disorders: H.W. Hoek, J.L. Treasure and M.A. Katzman (Eds.): Wiley, Chichester, 1998, xi+529pp., £95.00.

151

Neurobiology of antidepressant withdrawal: implications for the longitudinal outcome of depression

152

Neurobiology of anxiety and fear: challenges for genomic science of the new millennium

153

Neurobiology of attention-deficit hyperactivity disorder

154

Neurobiology of atypical presentations among medicare beneficiaries with unstable angina pectoris

155

Neurobiology of cocaine binging in pregnancy

156

Neurobiology of Decision Making: A Selective Review from a Neurocognitive and Clinical Perspective

157

Neurobiology of decision-making: quo vadis?

158

Neurobiology of decreased heart rate variability in older patients with recent acute coronary syndrome

159

Neurobiology of depression and reduced heart rate variability in coronary artery disease

160

Neurobiology of emotion perception I: the neural basis of normal emotion perception

161

Neurobiology of emotion perception II: implications for major psychiatric disorders

162

Neurobiology of exaggerated heart rate oscillations during two meditative techniques

163

Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions

164

Neurobiology of gender differences in reported symptoms for acute myocardial infarction

165

Neurobiology of HIV, psychiatric and substance abuse comorbidity research: Workshop report

166

Neurobiology of Nicotine Addiction: Implications for Smoking Cessation Treatment

167

Neurobiology of panic disorder

168

Neurobiology of prenatal influences on long-term psychomotor development in offspring of diabetic mothers

169

Neurobiology of prenatal maternal blood pressure response to stress

170

Neurobiology of psychosocial treatment of mental stress-induced myocardial ischemia in men

171

Neurobiology of Rett syndrome: a genetic disorder of synapse development

172

Neurobiology of Slow Coronary Flow

173

Neurobiology of speaking and stuttering

174

Neurobiology of Spinal Cord Injury, Edited by R.G. Kalb and S.M. Strittmatter, Humana Press, 1999, ISBN 0-896-03672-3. Hardcover: $125.00

175

Neurobiology of the obsessive–compulsive spectrum disorders

176

Neurobiology of Touretteʹs syndrome: concepts of neuroanatomic localization and neurochemical abnormalities

177

Neurobiology of U-Shaped Characteristic in Major Adverse Cardiac Events

178

Neurobiology of uterine irritability in preterm labor

179

180

Neuroblastoma – a developmental perspective

181

Neuroblastoma – developmental and molecular biology meet therapy design

182

Neuroblastoma accompanied by hyperaldosteronism

183

Neuroblastoma Associated with Bilateral Ptosis: Report of a Rare Condition

184

Neuroblastoma Characteristics and Embryonic Origin of The Primary Lesion Site: A SEER Study

185

Neuroblastoma directed therapy by a rational prodrug design of etoposide as a substrate for tyrosine hydroxylase

186

Neuroblastoma in a patient with 47, XXX karyotype

187

Neuroblastoma in Adulthood

188

Neuroblastoma in an XYY male

189

Neuroblastoma in chromosomal breakage syndromes

190

Neuroblastoma in Early Age with Rare Respiratory Manifestation

191

Neuroblastoma in Europe: differences in the pattern of disease in the UK

192

Neuroblastoma in Two Siblings Supports the Role of 1p36 Deletion in Tumor Development

193

Neuroblastoma mass screening in children

194

Neuroblastoma oligo-capping cDNA project: toward the understanding of the genesis and biology of neuroblastoma

195

Neuroblastoma screening: investing in the right test

196

Neuroblastoma susceptibility genes in human FRAGILOME sequences

197

Neuroblastoma targeting by c-myb-selective antisense oligonucleotides entrapped in anti-GD2 immunoliposome: immune cell-mediated anti-tumor activities

198

Neuroblastoma tumor cell-binding peptides identified through random peptide phage display

199

Neuroblastoma with MYCN amplification plus 11q deletion: immunohistochemical expression of angiogenic factors

200

Neuroblastoma: Therapeutic strategies for a clinical enigma

201

NEUROBLASTOMA;VARIABLE SYMPTOMS OF A NEUROGENIC TUMOR; A REPORT FROM IRAN

202

Neuroblastoma-like schwannoma in a case of schwannomatosis: Report of a rare case

203

Neuroblastoma-related severe hypoperfusion in the cerebellum of an infant: A case of opsoclonus-myoclonus syndrome

204

Neuroborreliosis

205

Neurobrucellosis and steroid therapy

206

Neurobrucellosis in a Patient With Multiple Sclerosis; A Case Report

207

Neurobrucellosis in Children, a Report of 2 Cases

208

Neurobrucellosis in systemic lupus erythematosus

209

Neurobrucellosis mimicking cerebral tumor: case report and literature review

210

Neurobrucellosis mimicking demyelinizating disorders

211

Neurobrucellosis Presented with a Hyperacute Onset: A Case Report

212

Neurobrucellosis Presented with a Hyperacute Onset: A Case Report

213

Neurobrucellosis Presenting with Unilateral Abducens Nerve Palsy

214

Neurobrucellosis: report of a rare disease in 20 Iranian patients referred to a tertiary hospital

215

Neurobrucellosis; A case report

216

Neurocardiogenic Mechanisms of Unexplained Syncope in Idiopathic Dilated Cardiomyopathy

217

Neurocardiogenic Syncope and Supraventricular Tachycardia in Association with a Rare Congenital Aortic Valve Abnormality

218

Neurochemical adaptation to cocaine abuse: reduction of N-acetyl aspartate in thalamus of human cocaine abusers

219

Neurochemical alterations in asymptomatic abstinent cocaine users: A proton magnetic resonance spectroscopy study

220

Neurochemical alterations of the entorhinal cortex in amnestic mild cognitive impairment (aMCI): A three-year follow-up study

221

Neurochemical analysis of amino acids, polyamines and carboxylic acids: GC–MS quantitation of tBDMS derivatives using ammonia positive chemical ionization

222

Neurochemical and behavioral effects of Cinnamomi cassiae (Lauraceae) bark aqueous extract in obese rats

223

Neurochemical and behavioral effects of green tea (Camellia sinensis): A model study

224

Neurochemical Approaches to Developing Biochemical Markers of Neurotoxicity: Review of Current Status and Evaluation of Future Prospects

225

Neurochemical bases of visceral nociception: Mathematical model

226

Neurochemical brain imaging investigations of schizophrenia

227

Neurochemical Changes in the Hippocampus of the Brown Norway Rat During Aging

228

Neurochemical diagnosis of Alzheimer’s dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau

229

Neuro-chemical Distortions among Patients with Leukaemia Receiving Chemotherapy

230

Neurochemical diversity of afferent neurons that transduce sensory signals from dog ventricular myocardium

231

Neurochemical Effects of Nicotine on Albino Rat’s Brain

232

Neurochemical effects of sleep deprivation in the hippocampus of the pilocarpine-induced rat model of epilepsy

233

Neurochemical imbalances linked to sleep disorders

234

Neurochemical Insights Into COVID-19-related Anosmia: A Commentary Study

235

Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains

236

Neurochemical mechanisms for cancer anorexia

237

Neurochemical Modulating Effect of Boswellia serrata Roxb. ex Colebr: A Preclinical Research

238

Neurochemical parameters of the main neurotransmission systems in aging mice

239

Neurochemical Profile of 8-Hydroxy-2-(Di-N-propylamino) tetralin (8-OH-DPAT) Induced Hyperphagia in Sugar Rich Diet Treated Rats

240

Neurochemical regulation of sleep

241

Neurochip logic design and simulation of an integrated classifier Original Research Article

242

Neurocinema: A brief overview

243

Neurocircuitry Models of Posttraumatic Stress Disorder and Extinction: Human Neuroimaging Research—Past, Present, and Future

244

Neurocircuitry of limbic dysfunction in anorexia nervosa

245

Neurocognition of auditory sentence comprehension: event related fMRI reveals sensitivity to syntactic violations and task demands

246

Neurocognitive alterations in first degree relatives of suicide completers

247

Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up

248

Neurocognitive and neuroimaging correlates of pediatric traumatic brain injury: A diffusion tensor imaging (DTI) study

249

Neurocognitive and symptomatic predictors of functional outcome in bipolar disorders: A prospective 1 year follow-up study

250

Neurocognitive changes after carotid revascularization: A review of the current literature

251

Neurocognitive changes in chronic liver disease

252

Neurocognitive changes in depressed patients in psychodynamic psychotherapy, therapy with fluoxetine and combination therapy

253

Neurocognitive characteristics of DUI recidivists

254

Neurocognitive Complications after Off-Pump and On-Pump CABG

255

Neurocognitive Complications after Ventricular Neuroendoscopy: A Systematic Review

256

Neurocognitive Correlates of Anxiety Disorders in Children:: A Preliminary Report

257

Neurocognitive correlates of CVLT performance in an academically impaired sample

258

Neurocognitive correlates of processing food-related stimuli in a Go/No-go paradigm

259

Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia

260

Neurocognitive correlates of white matter quality in adolescent substance users

261

Neurocognitive Decline After Off-Pump Versus On-Pump Coronary Artery Bypass

262

Neurocognitive deficit following coronary artery bypass grafting: a prospective study of surgical patients and nonsurgical controls

263

Neurocognitive deficits and psychiatric disorders in a NSW prison population

264

Neurocognitive Deficits in Individuals at Ultra-High-Risk for Psychosis: An Overview of Systematic Reviews

265

Neurocognitive development of children with congenital unilateral brain lesion and epilepsy

266

Neurocognitive disability, stroke, and surgery: A role for neuroergonomics

267

Neurocognitive dysfunction in antidepressant-free, non-elderly patients with unipolar depression: Alerting and covert orienting of visuospatial attention

268

Neurocognitive Dysfunction in Head Injured Patients, Does It Reveal Various Outcomes in Both Sexes and Age-Groups?

269

Neurocognitive effects after brief pulse and ultrabrief pulse unilateral electroconvulsive therapy for major depression: A review

270

Neurocognitive Effects In School Age Children Following Lead Exposure In Early Childhood

271

Neurocognitive effects of atypical and conventional antipsychotic drugs in schizophrenia: A naturalistic 6-month follow-up study

272

Neurocognitive Effects of Phenobarbital Discontinuation in children

273

Neurocognitive effects of phenobarbital discontinuation in epileptic children

274

Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression

275

Neurocognitive elements of antisocial behavior: Relevance of an orbitofrontal cortex account

276

Neurocognitive Function and Cerebral Emboli: Randomized Study of On-Pump Versus Off-Pump Coronary Artery Bypass Surgery

277

Neurocognitive function and quality of life in relation to hematocrit levels in chronic hemodialysis patients

278

Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects

279

Neurocognitive Function of Children suffering from Acute Lymphoblastic Leukemia in Southern Iran

280

Neurocognitive functioning and improvement in quality of life following participation in cardiac rehabilitation

281

Neurocognitive Functioning as a Predictor for Silent Infarction in Children with Sickle Cell Disease

282

Neurocognitive Functioning in AD/HD, Predominantly Inattentive and Combined Subtypes

283

Neurocognitive Functioning in Patients Undergoing Coronary Artery Bypass Graft Surgery or Percutaneous Coronary Intervention: Evidence of Impairment Before Intervention Compared With Normal Controls

284

Neurocognitive functioning in subjects with eating disorders: the influence of neuroactive steroids

285

Neurocognitive functioning in the prodrome of mania—an exploratory study

286

Neurocognitive functioning in young high-risk offspring having a parent with bipolar I disorder

287

Neurocognitive functions after aortic arch repair with right brachial artery perfusion

288

Neurocognitive functions and behavioral profiles in children with nephropathic cystinosis

289

Neurocognitive impairment after acute coronary syndrome: Prevalence and characterization in a hospital-based cardiac rehabilitation program sample

290

Neurocognitive impairment does not predict treatment outcome in obsessive–compulsive disorder

291

Neurocognitive impairment in adolescent major depressive disorder: State vs. trait illness markers

292

Neurocognitive impairment in middle-aged and older adults with bipolar disorder: Comparison to schizophrenia and normal comparison subjects

293

Neurocognitive inertia

294

Neurocognitive insights into substance abuse

295

Neurocognitive Manifestations of SARSCoV2: A Narrative Review of Mechanisms

296

Neurocognitive markers of psychosis in bipolar disorder: A meta-analytic study

297

Neurocognitive markers of psychosis in bipolar disorder: A meta-analytic study

298

Neurocognitive mechanisms of anxiety: an integrative account

299

Neurocognitive mechanisms of cognitive control: The role of prefrontal cortex in action selection, response inhibition, performance monitoring, and reward-based learning

300

Neurocognitive mechanisms underlying the experience of flow

301

Neurocognitive outcome after retrograde cerebral perfusion

302

Neurocognitive Outcomes 3 Years After Coronary Artery Bypass Graft Surgery: A Controlled Study

303

Neurocognitive outcomes following pediatric brain injury: A developmental approach

304

Neurocognitive Outcomes in Off-Pump Versus On-Pump Bypass Surgery: A Randomized Controlled Trial

305

Neurocognitive Outcomes of Off-Pump Versus On-Pump Coronary Artery Bypass: A Prospective Randomized Controlled Trial

306

Neurocognitive Performance in Children with ADHD and OCD

307

Neurocognitive performance using the Windows spaceflight cognitive assessment tool (WinSCAT) in human spaceflight simulations

308

Neurocognitive Profile in Adolescents with Early-Onset Schizophrenia: Clinical Correlates

309

Neurocognitive profile of children with Attention Deficit Hyperactivity Disorders (ADHD): A comparison between subtypes

310

Neurocognitive Profile of Children With Reading Disability in Kannada

311

Neurocognitive screening in Latinos: A comparison of the cross-cultural cognitive examination and the mini-mental state examination

312

Neurocomputational models of the remote effects of focal brain damage

313

Neurocomputing in Civil Infrastructure

314

Neurocontrol of a ball mill grinding circuit using evolutionary reinforcement learning

315

Neurocontrol of an aircraft: Application to windshear

316

Neuro-control of cable vibration using semi-active magneto-rheological dampers

317

Neuro-control of fixed offshore structures under earthquake

318

Neurocontrol of nonlinear systems via local memory neurons

319

Neurocontrol of Pressurized Water Reactors in Load-Follow Operations

320

Neurocontrol: A literature survey

321

Neurocontrol: Recent advances and links with the human brain

322

Neuro-controller design for nonlinear fighter aircraft maneuver using fully tuned RBF networks

323

Neuro-controller for reducing cyclic variation in lean combustion spark ignition engines

324

Neurocritical Care Unit Bed Allocation: Optimization Based on Prioritization Using Simulation

325

Neurocutaneous melanosis in an adult patient with diffuse leptomeningeal melanosis and a rapidly deteriorating course: Case report and review of the literature

326

Neurocutaneous syndromes: Behavioral features

327

Neurocycle Mind-management Approach: Effect on the Resiliency and Wellbeing of Female University Students

328

Neurocysticercosis - Islam and Other Religions

329

Neurocysticercosis and Oncogenesis

330

Neurocysticercosis immunodiagnosis using Taenia solium cysticerci crude soluble extract, excretory secretory and lower molecular mass antigens in serum and urine samples of Indian children

331

Neurocysticercosis in central Saudi Arabia

332

Neurocysticercosis in Europe: Still a public health concern not only for imported cases

333

Neurocysticercosis, mesial temporal lobe epilepsy, and hippocampal sclerosis: an association largely ignored

334

Neurocysticercosis: Changes after 25 Years of Medical Therapy

335

Neurocysticercosis: Changes After 25 Years of Medical Therapy

336

Neurocysticercosis: manifestations, diagnosis and treatment

337

Neurocysticercosis: manifestations, diagnosis and treatment

338

Neurocysticercosis: regional status, epidemiology, impact and control measures in the Americas

339

Neurocysticercosis: updated concepts about an old disease

340

Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome

341

Neurodegeneration as a mechanisms underlying ENS dysfunction: Translational concepts

342

Neurodegeneration in hereditary nucleotide repair disorders

343

Neurodegeneration with Brain Iron Accumulation: An Overview

344

Neurodegeneration, parkinsonian syndromes and autonomic failure

345

Neurodegeneration: a failure of neuroregeneration?

346

Neurodegeneration: new clues on inclusions Review Article

347

Neurodegenerations in domestic animals: a new way forward

348

Neurodegenerative aspects of protein aggregation

349

Neurodegenerative changes including altered tau phosphorylation and neurofilament immunoreactivity in mice transgenic for the serine/threonine kinase mos

350

NEURODEGENERATIVE DEMENTIA AND PARKINSONISM

351

Neurodegenerative diseases and oxidative stress

352

Neurodegenerative diseases and risk factors: A literature review

353

Neurodegenerative diseases in domestic animals: A comparative review

354

Neurodegenerative diseases: insights into pathogenic mechanisms from atherosclerosis

355

Neurodegenerative disorders, bullous pemphigoid and psoriasis: a comparative study in ethnic Poles indicates that Parkinson’s disease is more relevant to bullous pemphigoid

356

Neurodevelopment and the Transition from Schizophrenia Prodrome to Schizophrenia: Research Imperatives

357

Neurodevelopment of surviving infants at age two years, with a birthweight less than 2000 g and cared for in neonatal intensive care units (NICU)—results from a population based longitudinal study in Taiwan

358

Neurodevelopment outcomes and maternal methylmercury exposure: Breastfeeding is part of the solution not the problem

359

Neurodevelopment, Growth, and Viral Load in HIV-Infected Infants

360

Neurodevelopmental consequences of very preterm births

361

Neurodevelopmental course in pediatric onset progressive calcification of the basal ganglion: A case report

362

Neurodevelopmental damage after prenatal infection: Role of oxidative stress in the fetal brain

363

Neurodevelopmental differences in verbal fluency in children

364

Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study

365

Neurodevelopmental Disorders

366

Neurodevelopmental Disorders among Indian Children: Needs Attention

367

Neurodevelopmental effects of decabromodiphenyl ether (BDE-209) and implications for the Reference Dose

368

Neurodevelopmental Follow Up After Therapeutic Hypothermia for Perinatal Asphyxia

369

Neurodevelopmental integrity and zahavian bioacoustics

370

Neurodevelopmental Investigations among Methylmercury-Exposed Children in French Guiana

371

Neurodevelopmental outcome after laser therapy for twin-twin transfusion syndrome

372

Neurodevelopmental outcome at age two years amongst very low birth weight infants: results from a district general hospital

373

Neurodevelopmental outcome of congenital hypothyroidism in children between 1-5 years of age

374

Neurodevelopmental Outcome of Patients With Agenesis of Corpus Callosum

375

Neurodevelopmental outcome of premature infants after antenatal phenobarbital exposure

376

NEURODEVELOPMENTAL OUTCOME ONE YEAR AFTER EARLY VERSUS LATE SELECTIVE SURFACTANT TREATMENT

377

Neurodevelopmental outcome related to cerebral risk factors in children after neonatal arterial switch operation

378

Neurodevelopmental Outcomes of Infants with Benign Enlargement of the Subarachnoid Space

379

Neurodevelopmental outcomes of infants with birth weights of less than 1000 g: comparison between periods before and after the introduction of surfactant

380

Neurodevelopmental Outcomes of Seychellois Children from the Pilot Cohort at 108 Months Following Prenatal Exposure to Methylmercury from a Maternal Fish Diet,

381

Neurodevelopmental patterns of visual P3b in association with familial risk for alcohol dependence and childhood diagnosis

382

Neurodevelopmental Status in 3 - 5 Years-Old Children with a History of Congenital and Acquired Hypothyroidism

383

Neurodevelopmental Status of Infants Conceived Assisted Reproductive Techniques in Royan Institute

384

Neurodevelopmental Toxic Effects of Food Additives Used in Energy Drinks on Developing Rats

385

Neurodevelopmental toxicity of methylmercury: Laboratory animal data and their contribution to human risk assessment

386

Neurodevelopmental, immunological and endocrinological indices of perinatal human exposure to PCBs and dioxins

387

Neurodisruption of selective attention: insights and implications

388

Neuro-dynamic trading methods

389

Neurodynamical amplification of perceptual signals via system-size resonance

390

Neuroecology and psychological modularity

391

Neuroeconomics and the metastable brain

392

Neuroeconomics: cross-currents in research on decision-making

393

Neuroeconomics: Present and future

394

Neuroelectric and behavioral indices of interference control during acute cycling

395

Neuroelectric correlates of response production and inhibition in individuals at risk to develop alcoholism

396

Neuroelectrical signs of selective attention to color in boys with attention-deficit hyperactivity disorder

397

Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is it ecstasy or cannabis?

398

Neuroendocrine activation in heart failure is modified by endurance exercise training

399

Neuroendocrine Adenoma of Middle Ear Causing Acute Onset Facial Palsy- A Rare Case Report

400

Neuroendocrine aging in birds: Comparing lifespan differences and conserved mechanisms

401

Neuroendocrine and behavioral interaction in exposure treatment of phobic avoidance

402

Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas

403

Neuroendocrine and Clinical Characteristics of Major Depressed Patients Exhibiting Sleep-Onset REM

404

Neuroendocrine aspects of chronic fatigue syndrome: a commentary

405

Neuro-endocrine biomarkers of pollution-induced stress in marine invertebrates q

406

Neuroendocrine biomarkers, allostatic load, and the challenge of measurement: A commentary on Gersten

407

Neuroendocrine biomarkers, social relations, and the cumulative costs of stress in Taiwan

408

Neuroendocrine Cancer of Rectum Metastasizing to Ovary

409

Neuroendocrine carcinoma (carcinoid) of the thymus associated with Cushing’s syndrome

410

Neuroendocrine carcinoma associated with X-linked hyper-immunoglobulin M syndrome: Report of four cases and review of the literature

411

NEUROENDOCRINE CARCINOMA OF OVARY IN ASSOCIATION WITH MUCINOUS CYSTADENOMA

412

Neuroendocrine carcinoma of the ovotestis: A case report and review of literatures

413

Neuroendocrine Carcinoma of the Stomach; A Case Report

414

Neuroendocrine carcinoma of unknown primary: A systematic review of the literature and a comparative study with other neuroendocrine tumors

415

Neuroendocrine Carcinomas of the Stomach: Computed Tomography and Pathologic Findings in 32 Patients

416

Neuroendocrine cells in the vestibular glands of the genital tract of cows and pigs

417

Neuroendocrine changes in systemic lupus erythematosus and Sjögrenʹs syndrome

418

Neuroendocrine Consequences of Prenatal Androgen Exposure in the Female Rat: Absence of Luteinizing Hormone Surges, Suppression of Progesterone Receptor Gene Expression, and Acceleration of the Gonadotropin-Releasing Hormone Pulse Generator

419

Neuroendocrine correlates of chronic fatigue syndrome: A brief review

420

Neuro-endocrine correlates of ovarian development and egg-laying behaviors in the primitively eusocial wasp (Polistes chinensis)

421

Neuroendocrine differentiated carcinomas of the breast: a distinct entity

422

Neuroendocrine disruption and health effects in Elliptio complanata mussels exposed to aeration lagoons for wastewater treatment Original Research Article

423

Neuroendocrine disruption in Mya arenaria clams during gametogenesis at sites under pollution stress

424

Neuroendocrine evidence for dopaminergic actions of hypericum extract (LI 160) in healthy volunteers

425

Neuroendocrine facets of human puberty

426

Neuroendocrine factors affecting the steady-state levels of early trypsin mRNA in Aedes aegypti

427

Neuroendocrine factors alter host defense by modulating immune function

428

Neuroendocrine hormones such as growth hormone and prolactin are integral members of the immunological cytokine network

429

Neuroendocrine immune mechanisms in rheumatic diseases

430

Neuroendocrine immune responses to inflammation: the concept of the neuroendocrine immune loop

431

Neuroendocrine Influences and Repercussions of the Menopause

432

Neuroendocrine insights from the laboratory to the clinic

433

Neuroendocrine interactions in the immune system

434

Neuroendocrine involvement in aging: Evidence from studies of reproductive aging and caloric restriction

435

Neuroendocrine involvement in the aging: Evidence from studies of reproductive aging and caloric restriction

436

Neuroendocrine mechanisms for immune system regulation during stress in fish

437

Neuroendocrine mechanisms in fibromyalgia–chronic fatigue

438

Neuroendocrine regulation of gonadotropins in the male and the female

439

Neuroendocrine regulation of rearing behavior in the native Thai hen

440

Neuroendocrine regulation of seasonal morph development in a bivoltine race (Daizo) of the silkmoth, Bombyx mori L.

441

Neuroendocrine response to antipsychotics: effects of drug type and gender

442

Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome

443

Neuroendocrine secretory protein 55 (NESP55) immunoreactivity in male and female rat superior cervical ganglion and other sympathetic ganglia

444

Neuroendocrine stress response and hyperglycemia in children undergoing laparoscopic surgery: a comparative study between remifentanil infusion and fentanyl boluses during sevoflurane-based anesthesia

445

Neuroendocrine Study of Serotonin Function in Female Borderline Personality Disorder Patients: A Pilot Study

446

Neuroendocrine Tumor of the Gallbladder

447

Neuroendocrine tumors (carcinoid) of the thymic gland

448

Neuroendocrine tumors and conotruncal cardiac defects

449

Neuroendocrine tumors of the lung and octreotide scintigraphy

450

Neuroendocrine tumors of the lung and octreotide scintigraphy: reply

451

Neuroendocrine tumors of the thymus: a clinicopathological and prognostic study

452

Neuroendocrine tumours (carcinoids) of the appendix

453

Neuroendocrine tumours in various organ systems in a ten-year period

454

Neuroendocrine tumours: clinical presentation and management of localized disease

455

Neuroendocrine vs. Paracrine Control of Follicle-Stimulating Hormone

456

Neuroendocrine, Cognitive and Structural Imaging Characteristics of Women on Longterm Sickleave with Job Stress–Induced Depression

457

Neuroendocrine, polysomnographic and psychometric observations in healthy subjects at high familial risk for affective disorders: the current state of the ‘Munich vulnerability study’

458

Neuroendocrine–immune interactions in fish: a role for interleukin-1

459

Neuroendocrine–immune interactions in fish: a role for interleukin-1

460

Neuroendocrine-Induced Synthesis of Bone Marrow-Derived Cytokines with Inflammatory Immunomodulating Properties

461

Neuroendocrine-mediated alteration of CD8+ T cell and microglia immune function during the development of stress-induced herpes simplex virus type-1 (HSV-1) encephalitis

462

Neuroepidemiology not only for neuroepidemiologists

463

Neuroepithelial Cells Supply an Initial Transient Wave of MSC Differentiation

464

Neuroepithelial Stem Cell Proliferation Requires LIS1 for Precise Spindle Orientation and Symmetric Division

465

Neuro-estimator based GMC control of a batch reactive distillation

466

Neuroet: An easy-to-use artificial neural network for ecological and biological modeling

467

Neuroet: An easy-to-use artificial neural network for ecological and biological modeling

468

Neuroethical Theories

469

Neuroethics, reductionism and dualism

470

Neuroethics: A Moral Approach Towards Neuroscience Research

471

Neuroethics: An emerging new discipline in the study of brain and cognition

472

Neuroethics: the practical and the philosophical

473

Neuroethics; Neuroscience for Ethics and/or Ethics for Neuroscience New Challenge for Third Millennium

474

Neuroethological study of status epilepticus induced by systemic pilocarpine in Wistar audiogenic rats (WAR strain)

475

Neuroethology application for the study of human temporal lobe epilepsy: From basic to applied sciences

476

Neuro-evolutionary approach applied for optimizing the PEMFC performance

477

Neuro-evolutionary optimization methodology applied to the synthesis process of ash based adsorbents

478

Neurofascial Dextrose Prolotherapy for Managing Chronic Ankle Ligament Injury

479

Neurofeedback and epilepsy

480

Neurofeedback Effect on Perceptual-Motor Skills of Children with ADHD

481

Neurofeedback provides a better theta-rical performance

482

Neurofeedback Training Versus Perceptual-motor Exercises Interventions in Visual Attention for Children With Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial

483

Neurofeedback treatment of pseudoseizure disorder

484

Neuroferritinopathy: a neurodegenerative disorder associated with L-ferritin mutation

485

Neuroferritinopathy: A Window on the Role of Iron in Neurodegeneration

486

Neurofibrillary changes of the Alzheimer type in very elderly individuals: Neither inevitable nor benign: Commentary on “No disease in the brain of a 115-year-old woman”

487

Neurofibrillary degeneration and cell loss in the nucleus basalis in comparison to cortical Alzheimer pathology

488

Neurofibrillary pathology — correlation with hippocampal formation atrophy in Alzheimer disease

489

Neurofibrillary tangle-associated alteration of stathmin in Alzheimerʹs disease

490

Neurofibrillary tangles and plaques are not accompanied by white matter pathology in aged triple transgenic-Alzheimer disease mice

491

Neurofibroma of the breast in a boy with neurofibromatosis type 1

492

Neurofibroma of the Esophagus

493

Neurofibroma of the Sciatic Nerve with Neurofibromatosis Type 1

494

Neurofibroma with Bone Destruction Masquerading Extracranial Meningioma

495

Neurofibromas as bilateral cystic chest wall swellings

496

Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective

497

Neurofibromatosis 1 presenting as a rare widespread neurofibromas with cord compression

498

Neurofibromatosis 2 gene in human colorectal cancer

499

Neurofibromatosis 2 Phenotypes and Germ-Line NF2 Mutations Determined by an RNA Mismatch Method and Loss of Heterozygosity Analysis in NF2 Schwannomas

500

Neurofibromatosis of the Esophagus

501

Neurofibromatosis Presenting as Painless Clitoromegaly

502

Neurofibromatosis type 1 and hyperparathyroidism. Case report

503

Neurofibromatosis Type 1 and Type 2: review of the central nervous system and related structures

504

Neurofibromatosis type 1 with pregnancy-associated renovascular hypertension and the syndrome of hemolysis, elevated liver enzymes, and low platelets, ,

505

Neurofibromatosis type I (von Recklinghausen’s disease): A family case report and literature review

506

Neurofibromatosis with Bilateral Renal Artery Stenosis and End Stage Renal Disease: Case Report

507

Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning

508

Neurofibromin Regulation of ERK Signaling Modulates GABA Release and Learning

509

Neurofibrosarcoma of the duodenum

510

Neurofilament expression in the rat brain after cerebral infarction: effect of age

511

Neurofilament heavy chain gene polymorphism and risk of multiple sclerosis

512

Neurofilament light chain gene polymorphism and risk of multiple sclerosis in Iranian patients

513

Neurofilament M mRNA is Expressed in Conduction System Myocytes of the Developing and Adult Rabbit Heart,

514

Neuro-flow dynamics and the learning processes

515

Neurofolicullar hamartoma presenting as a rare adnexal neoplasm in association with basal cell carcinoma

516

Neurofunctional correlates of long-term arsenic exposure in humans

517

Neurofunctional correlates of personality traits in relapsing-remitting multiple sclerosis: An fMRI study

518

Neuro-fuzzy adaptive control based on dynamic inversion for robotic manipulators

519

NeuroFuzzy adaptive modelling and control : By Martin Brown and Chris Harris. Prentice-Hall, Englewood Cliffs, NJ (1994). IBSN 0-13-134453-6

520

Neuro-fuzzy and genetic algorithm in multiple response optimization

521

Neuro-fuzzy and neural network systems for air quality control

522

Neuro-fuzzy and neural network techniques for forecasting sea level in Darwin Harbor, Australia

523

Neuro-fuzzy approach for online message scheduling

524

Neuro-fuzzy approach for online message scheduling

525

Neuro-fuzzy approach to adaptive digital predistortion

526

Neurofuzzy approach to process parameter selection for friction surfacing applications

527

Neuro-fuzzy approach to processing inputs with missing values in pattern recognition problems Original Research Article

528

Neuro-fuzzy approach to real-time transient stability prediction based on synchronized phasor measurements

529

Neuro-fuzzy approach versus rough-set inspired methodology for intelligent decision support

530

Neuro-Fuzzy Approaches for Sanitary Sewer Pipeline Condition Assessment

531

Neuro-fuzzy ART-based document management system: application to mail distribution ، digital libraries

532

Neuro-Fuzzy Based Algorithm for Online Dynamic Voltage Stability Status Prediction Using Wide-Area Phasor Measurements

533

Neuro-fuzzy based constitutive modeling of undrained response of Leighton Buzzard Sand mixtures

534

Neuro-Fuzzy Based Performance Evaluation of Shunt Motor

535

Neuro-fuzzy based time-delay estimation using DCT coefficients

536

Neuro-fuzzy chip to handle complex tasks with analog performance

537

Neurofuzzy classification and rule generation of modes of radiowave propagation

538

Neuro-fuzzy closed-loop control of depth of anaesthesia

539

Neuro-fuzzy clustering of radiographic tibia image data using type 2 fuzzy sets

540

Neurofuzzy cognitive maps with adaptive B-splines

541

Neuro-fuzzy control for autonomous wind–diesel systems using biomass

542

Neurofuzzy control of a low-temperature desulphurization plant

543

Neuro-Fuzzy Control of a Robotic Exoskeleton With EMG Signals

544

Neuro-fuzzy control of bilateral teleoperation system using FPGA

545

Neurofuzzy control of modular and reconfigurable robots

546

Neuro-Fuzzy Control of Railcar Vibrations Using Semiactive Dampers

547

Neuro-fuzzy control of underwater vehicle-manipulator systems

548

Neuro-fuzzy controller for gas turbine in biomass-based electric power plant

549

Neurofuzzy design and model construction of nonlinear dynamical processes from data

550

Neuro-fuzzy dynamic model with Kalman filter to forecast irradiance and temperature for solar energy systems

551

Neuro-Fuzzy Estimation in Spatial Statistics

552

Neuro-Fuzzy Expert System for evaluating the performance of Distributed Software System Architecture

553

Neuro-fuzzy ID3: a method of inducing fuzzy decision trees with linear programming for maximizing entropy and an algebraic method for incremental learning

554

Neurofuzzy Inverse Jacobian Mapping for Multi-Finger Robot Hand Control

555

Neuro-fuzzy inverse model control structure of robotic manipulators utilized for physiotherapy applications

556

Neuro-fuzzy knowledge processing in intelligent learning environments for improved student diagnosis

557

Neuro-Fuzzy Logic Model for Evaluating Water Content of Sandy Soils

558

Neuro-fuzzy MIMO nonlinear control for ceramic roller kiln

559

Neuro-fuzzy mixture of experts network parallel learning and model construction algorithms

560

Neuro-fuzzy model of hybrid semi-active base isolation system with FPS bearings and an MR damper

561

Neuro-fuzzy Model-based Control

562

Neurofuzzy model-based predictive control of weld fusion zone geometry

563

Neuro-fuzzy modeling based genetic algorithms for identification of geochemical anomalies in mining geochemistry

564

Neuro-fuzzy modeling of rotation capacity of wide flange beams

565

Neuro-fuzzy modeling to adsorptive performance of magnetic chitosan nanocomposite

566

Neuro-fuzzy Modelling and Experimental Study of the Physiological Comfort of Green Cotton Fabric Based on Yarn Properties

567

Neuro-fuzzy modelling of power plant flue-gas emissions

568

Neuro-fuzzy network approach for modeling submicron MOSFETs: application to MOSFET subcircuit simulation

569

Neuro-fuzzy network for flavor recognition and classification

570

Neuro-fuzzy network for the classification of buried pipe defects

571

Neurofuzzy network model construction using Bezier-Bernstein polynomial functions

572

Neurofuzzy network modelling ، control of steam pressure in 300 MW steam-boiler system

573

Neuro-fuzzy networks ، their application to fault detection of dynamical systems

574

Neuro-fuzzy networks for voltage security monitoring based on synchronized phasor measurements

575

Neuro-fuzzy pattern classification for fault diagnosis in nuclear components

576

Neuro-fuzzy reasoning for occluded object recognition

577

Neuro-fuzzy relational systems for nonlinear approximation and prediction Original Research Article

578

Neuro-fuzzy river ice breakup forecasting system

579

Neuro-Fuzzy Sensor Fault Diagnosis of an Induction Motor

580

Neuro-fuzzy Sliding Mode Controller Based on a Brushless Doubly Fed Induction Generator

581

Neuro-fuzzy soft-switching hybrid filter for impulsive noisy environments

582

Neuro-fuzzy speed control of traveling-wave type ultrasonic motor drive using frequency and phase modulation

583

Neuro-fuzzy speed tracking control of traveling-wave ultrasonic motor drives using direct pulsewidth modulation

584

Neurofuzzy state identification using prefiltering

585

Neuro-fuzzy synergism to the intelligent system for edge detection and enhancement

586

Neuro-fuzzy system in partitioned client-side Web cache

587

Neuro-fuzzy system to predict permeability and porosity from well log data: A case study of Hassi R׳Mel gas field, Algeria

588

Neuro-fuzzy system with high-speed low-power analog blocks

589

Neuro-fuzzy system with learning tolerant to imprecision

590

Neuro-fuzzy systems for diagnosis

591

Neuro-fuzzy systems for function approximation

592

Neuro-fuzzy techniques for traffic control

593

Neuro-fuzzy TSK network for calibration of semiconductor sensor array for gas measurements

594

Neuro-fuzzy uncertainty de-coupling: a multiple-model paradigm for fault detection and isolation

595

Neuro-Fuzzy-Based Solar Cell Model

596

Neurofuzzy-model-following control of MIMO nonlinear systems

597

Neurogastroenterology: imaging of the sensory and motor control of the GI tract

598

Neurogenesis and depression: etiology or epiphenomenon?

599

Neurogenesis and Helplessness Are Mediated by Controllability in Males But Not in Females

600

Neurogenesis and neural stem cells in the dorsal vagal complex of adult rat brain: New vistas about autonomic regulations—a review

601

Neurogenesis in adulthood: a possible role in learning

602

Neurogenesis in gerbil hippocampus following brain ischemia: Focus on the involvement of metalloproteinases

603

Neurogenesis interferes with the retrieval of remote memories: Forgetting in neurocomputational terms

604

Neuro-genetic approach for optimisation of the spectrophotometric catalytic determination of cobalt

605

Neuro-genetic approach for optimisation of the spectrophotometric catalytic determination of cobalt Original Research Article

606

Neuro-genetic approach to multidimensional fuzzy reasoning for pattern classification

607

Neuro-genetic multioptimization of the determination of polychlorinated biphenyl congeners in human milk by headspace solid phase microextraction coupled to gas chromatography with electron capture detection Original Research Article

608

Neuro-genetic non-invasive temperature estimation: Intensity and spatial prediction

609

Neuro-genetic PID autotuning: time invariant case Original Research Article

610

Neuro-genetic prediction of software development effort

611

Neurogenetics study was unethical, says NNI report

612

Neurogenic and non-neurogenic mechanisms in response of rat distal colon muscle to dextran sulphate sodium treatment

613

Neurogenic cardiac damage and sudden death

614

Neurogenic cells in human amniotic fluid

615

Neurogenic claudication by epidural lipomatosis: a case report and review of literature

616

Neurogenic cluttering

617

Neurogenic Communication Disorders: a Functional Approach, Edited by L.E. Worrall, C.M. Frattali. New York/Stuttgart, Thieme 2000. TNY ISBN 0-96577-868-X; GTV ISBN 3-13-124471-2

618

Neurogenic essential hypertension revisited: the case for increased clinical and research attention

619

Neurogenic factors in hypertension caused by renal injury

620

Neurogenic failures of the external urethral sphincter closure and relaxation; a videourodynamic study

621

Neurogenic induction of human dental pulp derived stem cells by hanging drop technique, basic fibroblast growth factor, and SHH factors

622

Neurogenic myocardial dysfunction related to pulsatile compression of medulla by aneurysm

623

Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis

624

Neurogenic ST depression in stroke

625

Neurogenic stunned myocardium in a patient with metastatic brain tumors

626

Neurogenic stuttering versus developmental stuttering: An observer judgement study

627

Neurogenic tumors of the mediastinum originated from the vagus nerve

628

Neurogenic Vocal Fold Motion Impairment After Routine Intubation for Tonsillectomy in a Pediatric Patient

629

Neurogenin Promotes Neurogenesis and Inhibits Glial Differentiation by Independent Mechanisms

630

Neurogenins in brain development and disease: An overview

631

Neurogenomics—a capital investment?

632

Neuroglial response after induction of experimental allergic encephalomyelitis in susceptible and resistant rat strains

633

Neuroglial-mediated immunoinflammatory responses in Alzheimerʹs disease: Complement activation and therapeutic approaches

634

Neuroglobin and Prion Cellular Localization: Investigation of a Potential Interaction

635

Neuroglobin as a Neuroprotective in Neonates with Hypoxic Ischemic Encephalopathy

636

Neuroglobin might protect brain cells during stroke

637

Neuroglobin protects PC12 cells against β-amyloid-induced cell injury

638

Neuroglycopenic and other symptoms in patients with insulinomas

639

Neurographic assessment of lesions of single proper digital nerves

640

Neurohealth Properties of Hericium erinaceus Mycelia Enriched with Erinacines

641

Neurohormonal activation and diagnostic value of cardiac peptides in patients with suspected mild heart failure

642

Neurohormonal activation and left ventricular ejection fraction in patients with suspected myocardial ischemia

643

Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: Relation to hemodynamic variables and endothelin levels

644

Neurohormonal activation in patients with systemic sclerosis-related pulmonary arterial hypertension

645

Neurohormonal activation in severe heart failure: Relations to patient death and the effect of treatment with flosequinan

646

Neurohormonal activation rapidly decreases after intravenous therapy withdiuretics and vasodilators for class IV heart failure

647

Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension, , ,

648

Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure

649

Neurohormonal and dietary influences on hippocampal-dependent inhibitory controls of food intake

650

Neurohormonal blockade in chronic heart failure: How much is enough? can there be too much?

651

Neurohormonal changes in medical students during academic stress

652

Neurohormonal factors in the development of catabolic/anabolic imbalance and cachexia

653

Neurohormonal Inhibition in Heart Failure: Insights from Recent Clinical Trials

654

Neurohormonal modulation in cardiovascular disease

655

Neurohormonal perturbations in fibromyalgia

656

Neurohormonal prediction of mortality following admission for decompensated heart failure

657

Neurohormonal Response to Head-Up Tilt and Its Role in Vasovagal Syncope

658

Neurohormonal responses during positive pressure mechanical ventilation

659

Neurohormonal, Structural, and Functional Recovery Pattern After Premature Ventricular Complex Ablation Is Independent of Structural Heart Disease Status in Patients With Depressed Left Ventricular Ejection Fraction: A Prospective Multicenter Study

660

Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine

661

Neurohormones as markers of right- and left-sided cardiac dimensions and function in patients with untreated chronic heart failure

662

Neurohumoral activations in congestive heart failure: Correlations with cardiac function, heart rate variability, and baroreceptor sensitivity,

663

Neurohumoral Cardiovascular Responses to Alcohol and Their Modulation by Peroral Fluid

664

Neurohumoral characteristics of older hypertensive patients with abnormal nocturnal blood pressure dipping

665

Neurohumoral measurements as indicators of bong-terns prognosis after acute myocardial infarction

666

Neurohumoral regulation in ischemia-induced heart failure: Role of the forebrain

667

Neurohumoral variability in left ventricular dysfunction

668

Neuro-hypnotism: Prospects for hypnosis and neuroscience

669

Neurohypophyseal peptides in aging and Alzheimer’s disease

670

Neuro-imagerie et états de stress post-traumatiques

671

Neuroimages of disseminated neurotuberculosis: Report of one case

672

Neuroimaging – Chance effects and unintended consequences

673

Neuroimaging and Attention-Deficit/Hyperactivity Disorder in the 21st Century: What to Consider and How to Proceed

674

Neuroimaging and early Alzheimerʹs disease

675

Neuroimaging and neuroenergetics: Brain activations as information-driven reorganization of energy flows

676

Neuroimaging correlates of anxiety after pediatric traumatic brain injury

677

Neuroimaging Evaluation for First Attack of Unprovoked Nonfebrile Seizure in Pediatrics: When to Order?

678

NEUROIMAGING FINDING OF ORGANIC ACADEMIA IN CHILDREN

679

Neuroimaging Findings in First Unprovoked Seizures: A Multicentric Study in Tehran

680

Neuroimaging findings in frontotemporal lobar degeneration spectrum of disorders

681

Neuroimaging in bipolar disorder: what have we learned?

682

Neuroimaging in borderline personality disorder

683

Neuroimaging in Cerebral Palsy – Report from North India

684

NEUROIMAGING IN CHILDREN WITH FIRST AFEBRILE SEIZURES: TO ORDER OR NOT TO ORDER?

685

Neuroimaging in chronic fatigue syndrome

686

Neuroimaging in communication sciences and disorders: An introduction

687

Neuroimaging in Iran: A Review

688

Neuroimaging in ophthalmology

689

Neuroimaging in Outpatients with Tension Type Headache

690

Neuroimaging in Pediatric Optic Neuritis: A Narrative Review

691

Neuroimaging in psychiatry: an update

692

Neuroimaging in sexual offenses and paraphilia: A call to harmonize current clinical and imaging assessments in sexual offenses and paraphilia

693

Neuroimaging of emotion and personality: Scientific evidence and ethical considerations

694

Neuroimaging of Higher Cognitive Function

695

Neuroimaging of interval timing

696

Neuroimaging of Performance Monitoring: Error Detection and Beyond

697

Neuroimaging on delayed postanoxic encephalopathy with lesions localized in basal ganglia

698

NEUROIMAGING OUTCOMES IN CLINICAL TRIALS IN ALZHEIMER’S DISEASE

699

Neuroimaging research and the neurobiology of obsessive–compulsive disorder: where do we go from here?

700

Neuroimaging resolution of the altered state hypothesis

701

Neuroimaging studies in Rett syndrome

702

Neuroimaging studies of delirium: A systematic review

703

Neuroimaging studies of mood disorder effects on the brain

704

Neuroimaging studies of mood disorders

705

Neuroimaging studies of obsessive–compulsive disorder in adults and children

706

Neuroimaging studies of practice-related change: fMRI and meta-analytic evidence of a domain-general control network for learning

707

Neuroimaging studies of psychological interventions for mood and anxiety disorders: Empirical and methodological review

708

Neuroimaging studies of speech: An overview of techniques and methodological approaches

709

Neuroimaging studies of the cerebellum: language, learning and memory

710

Neuroimaging study of myotonic dystrophy. I. Magnetic resonance imaging of the brain

711

Neuroimaging study of myotonic dystrophy. II. MRI measurements of the brain

712

Neuroimaging techniques offer new perspectives on callosal transfer and interhemispheric communication

713

Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapy

714

Neuroimaging, Uncertainty, and the Problem of Dispositions

715

Neuroimaging, Volume I Basic Science; Volume II Clinical Applications, , : edited by Erin D. Bigler, New York: Plenum Press, 1996, Volume I, 342 pp. and Volume II, 365 pp.

716

Neuroimaging. Cambridge medical reviews — neurobiology and psychiatry, vol. 3

717

NEURO-IMAGING: STRUCTURAL AND FUNCTIONAL IMAGING

718

Neuroimaging-based approaches in the brain–computer interface

719

Neuroimaging-based markers of bipolar disorder: Evidence from two meta-analyses

720

Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder

721

Neuroimmune appendicitis Original Research Article

722

Neuroimmune appendicitis, peptides, and schizophrenia

723

Neuro-immune connection in spread of prions in the body?

724

Neuro-immune connections: evidence for a neuro-immunological synapse

725

Neuro-immune interactions in the lung

726

Neuroimmune networks and communication pathways: the importance of location

727

Neuroimmune response and sleep studies after whole body irradiation with high-LET particles Original Research Article

728

Neuroimmunoendocrine circuitry of the ‘brain-skin connection’

729

Neuroimmunology of the paraneoplastic neurological degenerations

730

Neuroimmunotoxic Effects of Occupational Exposure to Lead and Mercury

731

Neuroinfections: celebrating the past, discussing the present

732

Neuroinflammation and Alzheimer’s disease: critical roles for cytokine/Aβ-induced glial activation, NF-κB, and apolipoprotein E

733

Neuroinflammation and anti-inflammatory therapy for Alzheimer’s disease

734

Neuroinflammation in Autism Spectrum Disorders: the Role of High Mobility Group Box 1 Protein

735

Neuroinflammation in multiple sclerosis: Evidence for autoimmune dysregulation, not simple autoimmune reaction

736

Neuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimerʹs Disease

737

Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development

738

Neuroinflammatory State of Multiple Sclerosis and Strategies for Biotherapeutics Development

739

Neuroinformatics Research for Vision Science: NRV project

740

Neuroinformatics: A new tool for studying the brain

741

Neurointensive care unit system for continuous electrophysiological monitoring with remote web-based review

742

Neuroinvasion by Chandipura virus

743

Neurokinin B peptide serum levels are higher in normotensive pregnant women than in preeclamptic pregnant women

744

Neurokinin-1 receptor expression in the mature dental pulp of rats

745

Neurokinin-1 receptors in the cerebrovascular vasoactive intestinal polypeptide-containing nerves in the rat

746

Neurolathyrism in Ethiopia: assessment and comparison of knowledge and attitude of health workers and rural inhabitants

747

Neurolaw and consciousness detection

748

Neurolaw: A brief introduction.

749

Neuroleptic binding to sigma receptors: Possible involvement in neuroleptic-induced acute dystonia

750

Neuroleptic discontinuation in clinical and research settings: scientific issues and ethical dilemmas

751

Neuroleptic drug exposure and treatment of parkinsonism in the elderly: A case-control study

752

Neuroleptic Malignant Syndrome

753

Neuroleptic Malignant Syndrome (NMS) on Clozapine with aPotential Atypical Interaction with Paliperidone

754

Neuroleptic malignant syndrome after venlafaxine

755

Neuroleptic malignant syndrome after venlafaxine

756

Neuroleptic malignant syndrome after venlafaxine Original Research Article

757

Neuroleptic malignant syndrome and catatonia: One entity or two?

758

Neuroleptic malignant syndrome and catatonia: One entity or two?

759

Neuroleptic malignant syndrome associated with nortriptyline

760

Neuroleptic malignant syndrome in a burn patient

761

Neuroleptic malignant syndrome in the burns patient?

762

Neuroleptic Malignant Syndrome Revisited in the Perspective of Pakistan

763

Neuroleptic malignant syndrome with gangliosidosis type II

764

Neuroleptic malignant-like syndrome in an elderly patient caused by abrupt withdrawal of tolcapone, a catechol-O-methyl transferase inhibitor

765

Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimerʹs disease

766

Neuroleptic sensitivity to risperidone in Lewy body dementia

767

Neuroleptic treatment and caudate plasticity

768

Neuroleptic-induced akathisia and early onset tardive dyskinesia in affective disorder due to Cushingʹs syndrome

769

Neuroleptic-induced tardive dyskinesia among Arab psychotic patients

770

Neuroleptics in progressive structural brain abnormalities in psychiatric illness

771

Neuroleptiques et sujet âgé

772

Neuro-levelset system based segmentation in dynamic susceptibility contrast enhanced and diffusion weighted magnetic resonance images

773

Neuroligin Expressed in Nonneuronal Cells Triggers Presynaptic Development in Contacting Axons

774

Neuro-linguistic approach to pattern recognition

775

Neurolinguistic aspects of attrition

776

Neurolinguistic Programming (NLP) and Transformational Leadership: A Conceptual Model for Malaysian Women Leader and Representative

777

NEUROLINGUISTIC PROGRAMMING (NLP): ITS OVERVIEW AND REVIEW IN THE LENSES OF PHILOSOPHY AND PEDAGOGY

778

Neurolinguistics. An Introduction to Spoken Language Processing and its Disorders, John Ingram. Cambridge University Press, Cambridge (Cambridge Textbooks in Linguistics) (2007)

779

Neurologic and developmental disability after extremely preterm birth

780

Neurologic and otologic findings in Fisherʹs syndrome

781

Neurologic complications after graft replacement of the entire thoracoabdominal aorta

782

Neurologic complications after total shoulder arthroplasty

783

Neurologic complications including paralysis after a medication error involving implanted intrathecal catheters

784

Neurologic complications of coronary artery bypass grafting: Diffuse or focal ischemia?

785

Neurologic Complications of Methanol Poisoning: A Clinicoepidemiological Report from Poisoning Treatment Centers in Tehran, Iran

786

Neurologic complications of surgery for anterior shoulder instability

787

Neurologic complications of the Novacor left ventricular assist device

788

Neurologic disease and vitamin B12 deficiency

789

Neurologic Diseases Associated with Use of Plant Components with Toxic Potential

790

Neurologic drug-psychotropic drug update

791

Neurologic events after coronary bypass grafting: Further observations with warm cardioplegia

792

Neurologic exam

793

Neurologic Examination Abnormalities in Children with Bipolar Disorder or Attention-Deficit/Hyperactivity Disorder

794

Neurologic feature of horizontal gaze paly and progreive colioi with mutation in ROBO3

795

Neurologic infections in a Nigerian university teaching hospital

796

Neurologic injury in cardiac surgical patients with a history of stroke

797

NEUROLOGIC MANIFESTATION OF ORGANIC ACADEMIA

798

Neurologic manifestations and treatment of Henoch–Schönlein purpura

799

Neurologic manifestations in patients with COVID-19: A case report

800

Neurologic Manifestations in Staphylococcus aureus Endocarditis: A Review of 260 Bacteremic Cases in Nondrug Addicts

801

Neurologic Manifestations of Childhood Rheumatic Diseases

802

Neurologic Monitoring on Cardiopulmonary Bypass: What Are We Obligated to Do?

803

Neurologic outcome after thoracic and thoracoabdominal aortic aneurysm repair

804

Neurologic outcome in octogenarians after aortic arch repair with hypothermic circulatory arrest

805

Neurologic outcome in patients with MRI pattern of damage typical for neonatal hypoglycemia

806

Neurologic Presentations of COVID-19: A Case Series

807

Neurologic Preservation by Na+-H+ Exchange Inhibition Prior to 90 Minutes of Hypothermic Circulatory Arrest

808

Neurologic Sequelae Associated With Deep Hypothermic Circulatory Arrest

809

Neurologic sequelae of deep hypothermic circulatory arrest in cardiac transplant infants

810

Neurologic signs and mobility limitations: a neglected link in the elderly

811

Neurologic soft signs and low birthweight: their association and neuropsychiatric implications

812

Neurological Abnormalities in Schizophrenic Twins

813

Neurological adverse event after administration of the hepatitis A vaccine

814

NEUROLOGICAL AND NEUROPSYCHIATRIC SPECTRUM OF WILSON S DISEASE IN LOCAL POPULATION

815

Neurological and neuropsychological characteristics of occipital, occipito-temporal and occipito-parietal infarction

816

Neurological and neuropsychological signs in obsessive compulsive disorder: interaction with behavioural treatment

817

NEUROLOGICAL AND OTHER MANIFESTATIONS OF WILSON DISEASE; 1998-2005

818

Neurological and psychological sequelae in transplant recipients after bridging with the bioartificial liver

819

Neurological and Vascular Manifestations of Ethylmalonic Encephalopathy

820

Neurological artform

821

Neurological aspects of hair growth

822

Neurological aspects of multiple myeloma and related disorders

823

Neurological aspects of spinal-cord repair: promises and challenges

824

Neurological aspects of the Angelman syndrome

825

Neurological bases for balance–anxiety links

826

Neurological bases of behavioral development in infancy

827

Neurological basis of skill learning

828

Neurological cases for experts only!

829

Neurological comorbidity affects prognosis in left ventricular hypertrabeculation/noncompaction

830

Neurological Complication of Infective Endocarditis Misdiagnosing with Multiple Sclerosis: A Case Report

831

Neurological complications and Japanese encephalitis vaccination

832

Neurological Complications Following Percutaneous Coronary Interventions (A Report from the 2000–2001 New York State Angioplasty Registry)

833

Neurological complications in heparin-induced thrombocytopenia

834

Neurological complications in renal failure: a review

835

Neurological complications in β-thalassemia

836

Neurological Complications of Corona Virus: A Mini-Review

837

Neurological complications of HIV infection

838

Neurological complications of HIV infection

839

Neurological Compromise Associated With COVID-19 Is Broader Than Anticipated Comment on “COVID-19 Pandemic and Neurological Disease: A Critical Review of the Existing Literature”

840

Neurological Crises after Discontinuation of Nitisinone (NTBC) Treatment in 3 Cases of Tyrosinemia

841

Neurological deficit as the first manifestation of vesical transitional cell carcinoma

842

neurological deficit following combined spinal-Epidural Anesthesia for knee arthroplasty

843

Neurological Disorders and Oxidative Toxic Stress: A Role of Metal Nanoparticles

844

Neurological disorders and the structure of human consciousness

845

Neurological disorders caused by inherited ion-channel mutations

846

Neurological Disorders due to Recurrent Hypoglycemia

847

Neurological disturbances due to filgrastim

848

Neurological Dysfunction in Elderly Patients Undergoing Coronary Artery Bypass Operation

849

Neurological effects of high-dose idebenone in patients with Friedreichʹs ataxia: a randomised, placebo-controlled trial

850

Neurological efficacy of stavudine, zidovudine, and lamivudine

851

Neurological efficacy of stavudine, zidovudine, and lamivudine

852

Neurological evaluation and intelligence testing in the child with operated congenital heart disease

853

Neurological Examination and Hearing Assessment of Premature Infants with Gestational Age of Less Than 32 Weeks at Follow-up

854

Neurological examination findings to predict limitations in mobility and falls in older persons without a history of neurological disease

855

Neurological finding of Mitochondrial Syndromes (MERRF and MELAS)

856

Neurological findings and outcome in adult cerebral malaria

857

Neurological Functions of CEO Investment based on Varimax Analysis and Rotated Matrix in Q Typology

858

Neurological gait disorders in elderly people: clinical approach and classification

859

NEUROLOGICAL IMPROVEMENT AFTER CERVICAL TRACTION IN PATIENTS WITH CERVICAL SPINE INJURY

860

Neurological infection

861

Neurological infection in The Lancet Neurology

862

Neurological infections: clinical advances and emerging threats

863

Neurological infections: clinical advances, global threats

864

Neurological Involvement of Patients with COVID-19: Proposed Neuroinvasive Mechanisms and Management

865

Neurological manifestation of coeliac disease with particular emphasis on gluten ataxia and immunological injury: a review article

866

Neurological Manifestation of COVID-19: A Literature Review

867

Neurological Manifestations and Risk Factors of HTLV-1 Infection in the Middle East Region and Iran: A Comprehensive Review of 137 Articles of the Last 23 Years

868

Neurological Manifestations and their Correlated Factors in COVID-19 Patients; a Cross-Sectional Study

869

Neurological Manifestations as Presenting Feature of Osteopetrosis in Children; A Review of 11 Cases

870

Neurological Manifestations in Critically Ill COVID-19 Patients

871

Neurological manifestations in patients with antiphospholipid syndrome.

872

NEUROLOGICAL MANIFESTATIONS OF ALLGROVE SYNDROME

873

Neurological Manifestations of an Old Disease: A Case Report

874

Neurological manifestations of Behçet’s disease

875

Neurological Manifestations of Celiac Disease

876

Neurological manifestations of dengue infection Original Research Article

877

Neurological manifestations of Ehlers-Danlos syndrome(s): A review.

878

Neurological manifestations of Hansenʹs disease and their management

879

Neurological Manifestations of Hospitalized COVID-19-Infected Patients: A Single-Center Cohort Study

880

Neurological manifestations of knockout mice with β-galactosidase deficiency

881

Neurological Manifestations of Patients Hospitalized with Coronavirus Disease 2019 in Babol, Iran

882

Neurological Manifestations of Renal Diseases in Children in Qazvin/ Iran

883

NEUROLOGICAL MANIFESTATIONS OF WILSONʹS DISEASE

884

Neurological manifestations, diagnosis, and treatment of celiac disease: A comprehensive review

885

Neurological Measurement of Human Trust in Automation Using Electroencephalogram

886

Neurological mechanisms of green tea polyphenols in Alzheimerʹs and Parkinsonʹs diseases

887

Neurological melioidosis

888

Neurological Monitoring and Off-Pump Surgery in a Very High-Risk Stroke Patient

889

Neurological outcome and S100 after coronary artery bypass grafting and abdominal aortic surgery

890

Neurological outcome following delayed fixation of unstable thoracolumbar spinal injuries with short segment posterior fixation

891

Neurological outcome of normothermic versus hypothermic cardiopulmonary bypass in simple congenital heart diseases

892

Neurological outcomes in coronary surgery: independent effect of avoiding cardiopulmonary bypass

893

Neurological presentation of Griscelli syndrome: Obstructive hydrocephalus without haematological abnormalities or organomegaly

894

Neurological presentation of three patients with 22q11 deletion (CATCH 22 syndrome)

895

Neurological presentations of nutritional vitamin B12 deficiency in 42 breastfed infants in Southeast Turkey

896

Neurological prognosis correlated with variations over time in the number of subependymal nodules in tuberous sclerosis

897

Neurological recovery in 80 cases of rapid stereotactic evacuation and local fibrinolysis in spontaneous hematomas of putamen and thalamus

898

Neurological Rehabilitation of Stroke Patients by Means of a Robotically Assisted Brain Controlled Interface

899

Neurological sequelae following a high voltage electrical burn

900

Neurological sequelae in children born after in-vitro fertilisation: a population-based study

901

Neurological sequelae in in-vitro fertilisation babies

902

Neurological sequelae in in-vitro fertilisation babies

903

Neurological sequelae in in-vitro fertilisation babies

904

Neurological sequelae in in-vitro fertilisation babies

905

Neurological sequelae of cerebral malaria

906

Neurological sequelae of cerebral malaria

907

Neurological Sequels and Their Causes in Patients Hospitalized in the Toxicology Intensive Care Unit of Bahraloo Hospital, Tehran, Iran

908

Neurological soft signs and response to risperidone in chronic schizophrenia

909

Neurological soft signs in bipolar I disorder patients

910

Neurological soft signs in schizophrenia: Are they related to negative or positive symptoms, neuropsychological performance, and violence?

911

Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia

912

Neurological Soft Signs: A Further Step in the Diagnosis of Bipolar-I Disorder

913

Neurological Soft Signs: A Further Step in the Diagnosis of Bipolar-I Disorder?

914

Neurological Study of Radial Nerve Conduction During Endoscopic Radial Artery Harvesting:An Intra‐Operative Evaluation

915

Neurological Symptom in a Case of Adrenal Insufficiency

916

Neurological Symptoms as the First Presentation of Transitional Cell Carcinoma of Renal Pelvis

917

Neurological Wilson Disease in children: a three years experience from Multan

918

Neurologists are not immune

919

Neurologists determine the effect of migraine on quality of life

920

Neurologists give better stroke care

921

Neurologists say Florida woman is very unlikely to recover

922

923

Neurology elective at The Royal London Hospital

924

Neurology in sub-Saharan Africa—WHO cares?

925

Neurology of paediatric infectious diseases and immunodeficiency

926

Neurology of Touretteʹs syndrome (TS) TS as a developmental dopamine disorder: a hypothesis

927

Neurology of widely embedded free will

928

Neurology on the global health agenda

929

Neurology residency training in Europe: an Italian perspective

930

Neurology starters: simple to sublime

931

Neurology training around the world

932

Neurolymphomatosis as a single sign of tumor recurrence in a patient with diffuse large B-cell lymphoma of the testis

933

Neurolymphomatosis in Recrudescent Diffuse Large B-cell Lymphoma

934

Neurolymphomatosis of brachial plexus: A rare clinical presentation and the role of 18F-FDG PET/CT

935

Neuromagnetic activity in alpha and beta bands reflect learning-induced increases in coordinative stability

936

Neuromagnetic alpha suppression during an auditory Sternberg task: Evidence for a serial, self-terminating search of short-term memory

937

Neuromagnetic correlates of intra- and extra-dimensional set-shifting

938

Neuromagnetic effects on Anomalous Cognitive Experiences: A Critical Appraisal of the Evidence for Induced Sensed-presence and Haunt-type Experiences

939

Neuromagnetic imaging of cortical oscillations accompanying tactile stimulation

940

Neuromagnetic responses to vowels vs. tones reveal hemispheric lateralization

941

Neuromagnetic source localization of auditory evoked fields and intracerebral evoked potentials: a comparison of data in the same patients

942

Neuromarketing: beyond branding

943

Neuromarketing: Where marketing and neuroscience meet

944

Neuromedin B receptor antagonist suppresses tumor angiogenesis and tumor growth in vitro and in vivo

945

Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway

946

Neuromelanins in various regions of human brain are associated with native and oxidized isoprenoid lipids

947

Neurometabolic Diagnosis in Children who referred as Neurodevelopmental Delay (A Practical Criteria, in Iranian Pediatric Patients)

948

Neurometabolic Registry Site in Iran

949

950

Neuro-models for discharge air temperature system

951

Neuromodulation of parietal and motor activity affects motor planning and execution

952

Neuromodulation therapy does not influence blood flow distribution or left-ventricular dynamics during acute myocardial ischemia

953

Neuromodulation: acetylcholine and memory consolidation

954

Neuromodulation: An Overview

955

Neuromodulations of the Intractable Neurologic Symptoms

956

Neuromodulatory control of hippocampal function: towards a model of Alzheimer’s disease

957

Neuromodulatory role of Bacopa monnieri on oxidative stress induced by postnatal exposure to decabromodiphenyl ether (PBDE -209) in neonate and young female mice

958

Neuromodulatory unpaired median neurons in the New Zealand tree weta, Hemideina femorata

959

Neuromolecularware and its application to pattern recognition

960

Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation

961

Neuromonitoring for awareness during surgery

962

Neuromonitoring of the external branch of the superior laryngeal nerve during thyroid surgery

963

Neuro-monte carlo solution of electrostatic problems

964

Neuromorbidity in preterm twins in relation to chorionicity and discordant birth weight

965

Neuromorphic implementation of orientation hypercolumns

966

Neuromorphic Synapses for Artificial Dendrites

967

Neuromotor control in stuttering: Speech, orofacial nonspeech, and finger movements

968

Neuromotor Issues in Human Performance: Introduction

969

Neuromotor Issues in the Learning and Control of Golf Skill

970

Neuro-mucormycosis: Lessons from COVID-19-associated cases

971

Neuromuscular Adjustments of the Quadriceps Muscle After Eccentric Resistance and Concentric Resistance Training

972

Neuromuscular and balance responses to flywheel inertial versus weight training in older persons

973

Neuromuscular and Blood Lactate Response After a Motocross Training Session in Amateur Riders

974

Neuromuscular and Metabolic Responses to Three Different Resistance Exercise Methods

975

Neuromuscular and psychomotor abnormalities in patients with schizophrenia and their first-degree relatives

976

Neuromuscular and spatial constraints on bimanual hand-held pendulum oscillations: Dissociation or combination?

977

Neuromuscular Blockade After Ingestion of Tree Tobacco (Nicotiana glauca), ,

978

Neuromuscular blockade as part of an anaesthetic protocol for cataract surgery in an alpaca

979

Neuromuscular Blockade, Bariatric Surgeon Satisfaction, and Quality of Patient Recovery

980

Neuromuscular Blocking Agent Use in Acute Respiratory Distress Syndrome: Which Variable is Important?

981

NEUROMUSCULAR BLOCKING AGENTS IN THE INTENSIVE CARE UNITS

982

Neuromuscular changes in a rat model of colitis

983

Neuromuscular Characteristics of Endurance- and Power-Trained Athletes

984

Neuromuscular consequences of prolonged hunger strike: an electrophysiological study

985

Neuromuscular Control and Coordination During Cycling

986

Neuromuscular control model of the arm including feedback and feedforward components

987

Neuromuscular disease laboratory

988

Neuromuscular diseases: therapeutic advances

989

Neuromuscular disorder in response to anterior cruciate ligament creep

990

Neuromuscular disorders in critical illness

991

Neuromuscular disorders: molecular and therapeutic insights

992

Neuromuscular disorders: orphan diseases deserve attention

993

Neuromuscular disorders: therapeutic advances

994

Neuromuscular dysfunction associated with delayed weaning from mechanical ventilation in patients with respiratory failure

995

NEUROMUSCULAR EFFECTS OF CISATRACURIUM IN MORBIDLY OBESE PATIENTS

996

Neuromuscular Electric Stimulation Versus Traditional Treatment on Harris Hip Score in Cases of Avascular Necrosis of Femoral Head After Kidney Transplantation

997

NEUROMUSCULAR ELECTRICAL STIMULATION OF MEDIUM an‎d LOW FREQUENCY ON THE QUADRICEPS FEMORIS

998

Neuromuscular Electrical Stimulation of the Cricothyroid Muscle in Patients With Suspected Superior Laryngeal Nerve Weakness

999

Neuromuscular excitability properties in myotonic dystrophy type 1

1000

Neuromuscular function and bone density as independent predictors of fracture in older women: A 10-year longitudinal study

بازگشت